The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.
Arnott C, Huang Y, Neuen BL, Di Tanna GL, Cannon CP, Oh R, Edwards R, Kavalam M, Rosenthal N, Perkovic V, Jardine MJ, Mahaffey K, Neal B.
Arnott C, et al.
Diabetes Obes Metab. 2020 Oct;22(10):1753-1766. doi: 10.1111/dom.14091. Epub 2020 Jun 24.
Diabetes Obes Metab. 2020.
PMID: 32436638
Clinical Trial.